Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated in Delaware.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| PAHC | PHIBRO ANIMAL HEALTH CORP | 2026-08-31 09:56:12 | 37.44 | -0.2 | -0.53 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PAHC | 0001069899 | PHIBRO ANIMAL HEALTH CORP | US71742Q1067 | 549300U24SP4AF2JUX52 | 131840497 | Nasdaq | 2834 | Pharmaceutical Preparations | 0630 | DE | GLENPOINTE CENTRE EAST, 3RD FLOOR | TEANECK | NJ | 07666 | UNITED STATES | US | 201-329-7300 | GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ, 07666 | GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ, 07666 | PHILIPP BROTHERS CHEMICALS INC | — | — | — | 1,400 | https://pahc.com/ | 763,701,688 | 68,910,000 | — | Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated in Delaware. | 2026-08-27 20:12:11 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2026 | 763,701,688 | 341,059,923 | 80.6972 | — | — | — |
| 2025 | 422,641,765 | 187,821,436 | 79.9852 | — | — | — |
| 2024 | 234,820,329 | -37,108,912 | -13.6465 | — | — | — |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Larry L. Miller | Chief Operating Officer | 2025 | 710,850 | 1,162,500 | 0 | 488,150 | 54,869 | 2,429,538 |
| Daniel M. Bendheim | Director, Executive Vice President | 2025 | 575,000 | 100,000 | 0 | 394,850 | 47,258 | 1,119,780 |
| Jack C. Bendheim | Chief Executive Officer, President, Chairman Of The Board | 2025 | 2,442,600 | 500,000 | 0 | 1,677,300 | 496,135 | 5,284,122 |
| Glenn David | Chief Financial Officer | 2025 | 672,767 | 100,000 | 0 | 462,000 | 39,180 | 1,273,947 |
| Judith Weinstein | General Counsel, Senior Vice President, Corporate Secretary | 2025 | 500,000 | 150,000 | 0 | 343,350 | 47,701 | 1,043,927 |
| Fiscal Year | Employee Count |
|---|---|
| 2026 | 2,605 |
| 2025 | 2,475 |
| 2024 | 1,940 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenue | 1,518,093,000 | 1,296,215,000 | 1,017,679,000 |
| Cost Of Revenue | 1,005,578,000 | 896,273,000 | 704,587,000 |
| Gross Profit | 512,515,000 | 399,942,000 | 313,092,000 |
| Research And Development Expenses | 24,551,000 | 23,726,000 | 29,194,000 |
| General And Administrative Expenses | 318,119,000 | 289,477,000 | 259,777,000 |
| Operating Expenses | 318,119,000 | 289,477,000 | 259,777,000 |
| Operating Income | 194,396,000 | 110,465,000 | 53,315,000 |
| Net Income | 99,720,000 | 48,264,000 | 2,416,000 |
| Earnings Per Share Basic | 2.46 | 1.19 | 0.06 |
| Earnings Per Share Diluted | 2.43 | 1.19 | 0.06 |
| Weighted Average Shares Outstanding Basic | 40,546,000 | 40,515,000 | 40,504,000 |
| Weighted Average Shares Outstanding Diluted | 40,964,000 | 40,678,000 | 40,523,000 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Cash And Cash Equivalents | 61,419,000 | 68,039,000 | 70,613,000 |
| Marketable Securities Current | 20,575,000 | 9,000,000 | 44,000,000 |
| Accounts Receivable | 238,794,000 | 227,983,000 | 169,452,000 |
| Inventories | 534,883,000 | 444,425,000 | 265,911,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 79,835,000 | 61,159,000 | 51,021,000 |
| Total Assets Current | 935,506,000 | 810,606,000 | 600,997,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 369,174,000 | 354,690,000 | 203,300,000 |
| Other Assets Non Current | 106,464,000 | 99,490,000 | 78,297,000 |
| Total Assets Non Current | 565,735,000 | 550,294,000 | 381,187,000 |
| Total Assets | 1,501,241,000 | 1,360,900,000 | 982,184,000 |
| Accounts Payable | 127,314,000 | 138,201,000 | 85,567,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | — | — | 29,795,000 |
| Other Liabilities Current | 29,933,000 | 31,237,000 | 17,540,000 |
| Total Liabilities Current | 316,468,000 | 293,473,000 | 204,148,000 |
| Long Term Debt | — | — | 312,084,000 |
| Other Liabilities Non Current | 91,527,000 | 79,310,000 | 63,106,000 |
| Total Liabilities Non Current | 799,296,000 | 781,745,000 | 521,395,000 |
| Total Liabilities | 1,115,764,000 | 1,075,218,000 | 725,543,000 |
| Common Stock | 4,000 | 4,000 | 4,000 |
| Retained Earnings | 352,958,000 | 272,701,000 | 243,886,000 |
| Accumulated Other Comprehensive Income | -106,077,000 | -124,018,000 | -123,527,000 |
| Total Shareholders Equity | 385,477,000 | 285,682,000 | 256,641,000 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Depreciation And Amortization | 51,514,000 | 45,605,000 | 36,178,000 |
| Share Based Compensation Expense | 1,597,000 | 717,000 | 475,000 |
| Other Non Cash Income Expense | 1,913,000 | 1,643,000 | 2,098,000 |
| Change In Accounts Receivable | 7,493,000 | 55,208,000 | 8,678,000 |
| Change In Inventories | 86,338,000 | 44,294,000 | -2,641,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -1,591,000 | -1,572,000 | -3,922,000 |
| Change In Accounts Payable | -12,463,000 | 45,555,000 | 12,000,000 |
| Change In Other Liabilities | 26,351,000 | 47,159,000 | 12,189,000 |
| Cash From Operating Activities | 68,954,000 | 80,124,000 | 87,594,000 |
| Purchases Of Marketable Securities | 47,601,000 | 14,000,000 | 65,523,000 |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 59,088,000 | 38,293,000 | 41,238,000 |
| Acquisition Of Business | 1,305,000 | 286,529,000 | 3,282,000 |
| Other Investing Activities | 792,000 | -1,134,000 | -326,000 |
| Cash From Investing Activities | -71,455,000 | -288,688,000 | -48,194,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 19,463,000 | 19,449,000 | 19,442,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 297,000,000 | 532,000,000 | 276,000,000 |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -6,560,000 | 207,134,000 | -6,768,000 |
| Change In Cash | -6,620,000 | -2,574,000 | 29,332,000 |
| Cash At End Of Period | 61,419,000 | 68,039,000 | 70,613,000 |
| Income Taxes Paid | 20,623,000 | 13,400,000 | 15,430,000 |
| Interest Paid | 42,112,000 | 32,073,000 | 17,253,000 |
| Fiscal Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Earnings Per Share | 2.46 | 1.19 | 0.06 |
| Price To Earnings Ratio | 12.7642 | 21.4622 | 284 |
| Earnings Growth Rate | 106.7227 | 1,883.3333 | -92.5926 |
| Price Earnings To Growth Ratio | 0.1196 | 0.0114 | -3.0672 |
| Book Value Per Share | 9.5072 | 7.0513 | 6.3362 |
| Price To Book Ratio | 3.3028 | 3.622 | 2.6893 |
| Ebitda | 218,273,000 | 144,493,000 | 77,034,000 |
| Enterprise Value | — | — | 961,454,160 |
| Dividend Yield | 0.0153 | 0.0188 | 0.0282 |
| Dividend Payout Ratio | 0.1952 | 0.403 | 8.0472 |
| Debt To Equity Ratio | — | — | 1.3321 |
| Capital Expenditures | 65,998,000 | 196,995,000 | 43,910,000 |
| Free Cash Flow | 2,956,000 | -116,871,000 | 43,684,000 |
| Return On Equity | 0.2587 | 0.1689 | 0.0094 |
| One Year Beta | 1.1252 | 1.1619 | 0.8395 |
| Three Year Beta | 1.0924 | 0.9517 | 0.7438 |
| Five Year Beta | 0.9023 | 0.8661 | 0.893 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Bendheim Daniel M | Director, President and CEO | 2026-08-06 | 11,699 | A | 15,177 |
| Escudero Lisa Ann | — | 2026-08-06 | 1,547 | A | 3,434 |
| BENDHEIM JACK | Director, Executive Chairman, 10% owner | 2026-08-06 | 12,103 | A | 26,640 |
| Weinstein Judith | — | 2026-08-06 | 2,478 | A | 5,453 |
| BENDHEIM Jonathan | Director | 2026-08-06 | 2,716 | A | 5,984 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-06-30 | 891,980 | 28,407 | 31.4 |
| Fulcrum Asset Management LLP | 2026-06-30 | 1,400 | 44 | 31.8182 |
| Caitlin John, LLC | 2026-06-30 | 24,680 | 786 | 31.3995 |
| Parvin Asset Management, LLC | 2026-06-30 | 371,619 | 11,835 | 31.4 |
| Transamerica Financial Advisors, LLC | 2026-06-30 | 697 | 22 | 31.6818 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 2026-06-30 | INSTITUTIONAL SHARES | VBAIX | 11,182 | 351,114.8 | 0.0006 |
| VANGUARD VALLEY FORGE FUNDS | 2026-06-30 | ADMIRAL SHARES | VBIAX | 11,182 | 351,114.8 | 0.0006 |
| VANGUARD VALLEY FORGE FUNDS | 2026-06-30 | INVESTOR SHARES | VBINX | 11,182 | 351,114.8 | 0.0006 |
| VANGUARD INDEX FUNDS | 2026-06-30 | Institutional Select Shares | VSTSX | 659,626 | 20,712,256.4 | 0.0009 |
| VANGUARD INDEX FUNDS | 2026-06-30 | Institutional Plus Shares | VSMPX | 659,626 | 20,712,256.4 | 0.0009 |